Pro Pharmaceuticals Group to Attend CPHI Milan 2026

For ProPG, CPHI Milan is an important opportunity to strengthen international sourcing relationships. Our focus is European reference listed drug (RLD) and reference medicinal product sourcing, clinical-trial comparator supply, and bioequivalence-study sourcing for pharmaceutical sponsors, CROs, CDMOs and generic manufacturers.

CPHI brings together the full pharmaceutical supply chain, from raw materials through to finished-dose manufacturing, across thousands of exhibiting companies and visitors from around the world. ProPG's interest in Milan is specific: building and strengthening relationships with organisations that need hard-to-source reference products and comparators sourced from Europe, delivered reliably into clinical trials and generic-development programmes worldwide.

European RLD and Comparator Sourcing

At CPHI Milan, ProPG will prioritise conversations around European RLD sourcing, EU reference medicinal product sourcing, clinical-trial comparator sourcing, and bioequivalence-study sourcing for generic development.

Terminology varies by jurisdiction. Reference Listed Drug (RLD) is FDA and US terminology; reference medicinal product is the formal EU term for the equivalent concept. ProPG works across both frameworks, sourcing the reference or comparator product specified by the sponsor's regulatory strategy and study requirements, whether that's for an FDA bioequivalence submission, an EMA dossier, or a generic-development programme spanning multiple markets.

This also extends to hard-to-source and cold-chain products: comparators that are discontinued in some markets, held by a single manufacturer, or that require temperature-controlled logistics from source to site. These are the sourcing problems where an established European network and licensed pharmaceutical infrastructure can materially reduce sourcing friction and execution risk, and where a slow or unreliable source can delay a trial timeline or a generic-development milestone.

For a detailed look at how RLD sourcing and comparator sourcing work in practice, including the regulatory distinctions, common sourcing challenges, and what generic-development and clinical-trial teams need to plan for, see our article RLD and Comparator Sourcing from Europe: A Practical Guide for Clinical Trials and Generic Development. It's a detailed resource for teams working through European sourcing requirements ahead of a trial or filing, and it sits alongside our broader comparator and RLD sourcing service.

Connecting Australia and Europe

ProPG is a 100% Australian-owned pharmaceutical supplier focused on helping hospitals, sponsors and clinical-trial organisations access medicines and comparators that are difficult to source through routine channels. That model now spans Australia and Europe.

Our Australian base supports supply into Australian hospitals, clinical trials and sponsors under TGA-regulated pathways. Our European operations support sourcing, warehousing and GDP-compliant logistics from within the EU, with a presence in Hamburg, Germany, and in Warsaw, Poland. In Poland, our EU affiliate Jemstar provides logistics and warehousing infrastructure that supports fulfilment across the region.

These operations work through the licensing and quality arrangements appropriate to each location and activity. Together, they support sourcing, warehousing and international pharmaceutical supply across Europe, Australia and other markets.

Who ProPG Would Like to Meet at CPHI

ProPG is attending CPHI Milan 2026 as a registered visitor, and we're keen to meet organisations working on the sourcing side of clinical development and generic manufacturing, including:

• Pharmaceutical sponsors managing comparator and RLD requirements for active or upcoming trials

• Generic manufacturers and biosimilar developers sourcing reference products for development and bioequivalence work

• CROs and CDMOs managing clinical-trial supply chains across multiple markets

• Clinical-trial supply teams coordinating comparator logistics, including cold-chain requirements

• European pharmaceutical wholesalers and manufacturers with sourcing or distribution capability relevant to comparator supply

• Companies that need sourcing support into or out of Australia and Europe, for trials, generic development or hard-to-source products

  
  

If your team is working through any of these sourcing challenges, CPHI Milan is a practical place to start the conversation face to face.

Meet ProPG in Milan

ProPG will be at CPHI Milan 2026, 6–8 October 2026, Fiera Milano, Milan, Italy. If you'd like to arrange a short meeting during the event to discuss European RLD, reference medicinal product, comparator or clinical-trial sourcing requirements, contact us to set up a time.

We look forward to meeting sponsors, CROs, CDMOs, generic manufacturers and supply teams working on European sourcing in Milan this October.